归创通桥医疗科技股份有限公司（股票代码：02190）于2026年3月31日发布公告。公司当日在香港联交所场内回购股份，涉及数量为47,500股，占当时已发行股本约0.0141%。本次回购的每股价格介乎每股港币22.96元至24.10元之间，合计耗资约港币110.78万元。
回购完成后，公司已发行股份数量变动为328,800,613股，库存股数量增至7,550,131股，总股本维持336,350,744股。公司回购授权于2025年5月30日获得通过，本次回购符合香港联交所上市规则及相关法律规定。
本公告由公司董事赵中签署。公司确认本次回购事项已严格遵循所有适用的上市规则及监管要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.